Paid Clinical Trials Chandler

Discover 1,196 paid clinical trials in Chandler, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,196

PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Chandler AZ, Gilbert AZ, Mesa AZ, Scottsdale AZshow 39 more

Code:

NCT06760637

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07220060

letrozole

abemaciclib

palbociclib

ribociclib

Dato-DXd & PembrolizumabDatopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Recruiting

PHASE3

Sponsor:

Daiichi Sankyo

Location:

Chandler AZ, Prescott Valley AZ, Riverside CA, Newport Beach CAshow 27 more

Code:

NCT05555732

Conditions

Metastatic Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Datopotamab Deruxtecan

Pembrolizumab

Pemetrexed

Carboplatin

Cisplatin

Observational StudyChanges in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW)

Recruiting

Sponsor:

Brian Tiffany, MD

Location:

Chandler AZ

Code:

NCT04595175

Conditions

COVID-19 Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

OrthopulseStudy of the Use of Orthopulse Photobiomodulation

Recruiting

Sponsor:

Biolux Technology GmbH

Location:

Chandler AZ

Code:

NCT05650359

Conditions

Orthodontics

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

OrthoPulse

No intervention

CDK4/6 InhibitorThe CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Recruiting

PHASE3

Sponsor:

American Society of Clinical Oncology

Location:

Chandler AZ, Gilbert AZ, Mesa AZ, Scottsdale AZshow 49 more

Code:

NCT06377852

Conditions

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

Palbociclib 125mg

Ribociclib 600mg

Ribociclib

Palbociclib

BEM/RZR vs. SOF/VELC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Recruiting

PHASE3

Sponsor:

Atea Pharmaceuticals, Inc.

Location:

Chandler AZ, Mesa AZ, Phoenix AZ, Tucson AZshow 77 more

Code:

NCT06868264

Conditions

HEPATITIS C VIRUS CHRONIC INFECTION

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemnifosbuvir-Ruzasvir (BEM/RZR)

Sofosbuvir-Velpatasvir (SOF/VEL)

LY3848575Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Chandler AZ, Phoenix AZ, Fresno CA, Boulder COshow 26 more

Code:

NCT06568042

Conditions

Neuropathic Pain

Distal Sensory Polyneuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3848575

Placebo

GolcadomideStudy to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Recruiting

PHASE1

Sponsor:

Celgene

Location:

Chandler AZ, San Antonio TX, Orlando FL

Code:

NCT06535399

Conditions

Hepatic Impairment

Healthy Volunteers

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

BMS-986369

ABX-002Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Recruiting

PHASE2

Sponsor:

Autobahn Therapeutics, Inc.

Location:

Chandler AZ, Phoenix AZ, Tucson AZ, Oceanside CAshow 29 more

Code:

NCT06633016

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

ABX-002

Placebo

MevrometostatA Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Chandler AZ, Gilbert AZ, Mesa AZ, Scottsdale AZshow 33 more

Code:

NCT06551324

Conditions

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-06821497

Docetaxel

Enzalutamide

Paid Clinical Trials Chandler

Filter results

PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Dato-DXd & PembrolizumabDatopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Observational StudyChanges in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW)

OrthopulseStudy of the Use of Orthopulse Photobiomodulation

CDK4/6 InhibitorThe CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Interested in new trials?

BEM/RZR vs. SOF/VELC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

LY3848575Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

GolcadomideStudy to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

ABX-002Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

MevrometostatA Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).